Investor insights
Sectors invested in
Funding rounds participated in
$1.5M sweet spot round size
Most of their 19 investments are in rounds between $16M and $85M
Investor type
Basic info
Industry
Sectors
Investments made
Alentis Therapeutics raised $105M on April 13, 2023
Investors: Schroders Capital, Novo Holdings, RA Capital Management, L.P., JEITO and Pureos Bioventures
Mediar Therapeutics raised $85M on March 15, 2023
Investors: Gimv, Mission BioCapital, Bristol-Myers Squibb, UK, Sofinnova Partners and Pureos Bioventures
Undisclosed raised $23M on December 15, 2022
Investors: REPAIR Impact Fund, Sanofi Ventures, Adjuvant Capital, Industrifonden, Wellington Partners, Sunstone Life Science Ventures, Trill Impact and Pureos Bioventures
Araris Biotech AG raised $24M on October 4, 2022
Investors: Schroders Capital, b-to-v Partners AG, VI Partners AG, Redalpine and Pureos Bioventures
Tridek-One raised $16M on September 15, 2022
Investors: Bioqube Ventures, Advent Life Sciences, AdBio partners and Pureos Bioventures
Imcheck Therapeutics raised $100M on June 13, 2022
Investors: Gimv, The Invus Group, Earlybird Venture Capital, Eurazeo, The Leukemia & Lymphoma Society, Wellington Partners, EQT Life Sciences and Pureos Bioventures
Ariceum Therapeutics raised $27M on June 8, 2022
Investors: HealthCap, EQT Life Sciences and Pureos Bioventures
Engimmune Therapeutics raised $16M on May 3, 2022
Investors: Novo Holdings, Kinled Holding Ltd and Pureos Bioventures
Alentis Therapeutics raised $67M on June 15, 2021
Investors: Kinled Holding Ltd, BioMedPartners, High-Tech Gründerfonds, Morningside Venture Capital 晨兴资本, JEITO and Pureos Bioventures
Hummingbird Bioscience raised $125M on May 18, 2021
Investors: Octagon Capital Advisors, Polaris Partners, Heritas Capital, Frazier Healthcare Partners, Novo Holdings and Pureos Bioventures